Invesco
BEAM icon

Invesco’s Beam Therapeutics BEAM Stock Holding History

Invesco’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.24M Buy
219,961
+6,776
+3% +$188K ﹤0.01% 2167
2025
Q4 		$5.91M Buy
213,185
+36,321
+21% +$927K ﹤0.01% 2164
2025
Q3 		$4.29M Buy
176,864
+47,990
+37% +$955K ﹤0.01% 2296
2025
Q2 		$2.19M Buy
128,874
+40,583
+46% +$707K ﹤0.01% 2541
2025
Q1 		$1.72M Buy
88,291
+22,026
+33% +$577K ﹤0.01% 2594
2024
Q4 		$1.64M Buy
66,265
+2,701
+4% +$68.9K ﹤0.01% 2688
2024
Q3 		$1.56M Sell
63,564
-1,128
-2% -$29.1K ﹤0.01% 2723
2024
Q2 		$1.52M Sell
64,692
-677
-1% -$16.6K ﹤0.01% 2730
2024
Q1 		$2.16M Buy
65,369
+17,208
+36% +$536K ﹤0.01% 2634
2023
Q4 		$1.31M Sell
48,161
-1,870
-4% -$46.5K ﹤0.01% 2775
2023
Q3 		$1.2M Sell
50,031
-344
-0.7% -$9.22K ﹤0.01% 2784
2023
Q2 		$1.61M Sell
50,375
-282
-0.6% -$9.15K ﹤0.01% 2707
2023
Q1 		$1.55M Buy
50,657
+17,686
+54% +$698K ﹤0.01% 2737
2022
Q4 		$1.29M Buy
32,971
+4,219
+15% +$189K ﹤0.01% 2820
2022
Q3 		$1.37M Buy
28,752
+3,441
+14% +$196K ﹤0.01% 2799
2022
Q2 		$980K Buy
25,311
+3,004
+13% +$119K ﹤0.01% 3000
2022
Q1 		$1.28M Buy
22,307
+277
+1% +$18.2K ﹤0.01% 2965
2021
Q4 		$1.76M Sell
22,030
-1,305
-6% -$112K ﹤0.01% 2845
2021
Q3 		$2.03M Buy
23,335
+4,253
+22% +$427K ﹤0.01% 2800
2021
Q2 		$2.46M Buy
19,082
+8,864
+87% +$706K ﹤0.01% 2770
2021
Q1 		$818K Sell
10,218
-172,402
-94% -$16.4M ﹤0.01% 3130
2020
Q4 		$14.9M Buy
+182,620
New +$8.98M ﹤0.01% 1588

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Invesco's BEAM Position: Q1 2026 in Review

Invesco increased its Beam Therapeutics (BEAM) stake by 3.2% in Q1 2026, buying an estimated $188K and bringing the position to 219,961 shares worth $5.24M. The position accounts for ﹤0.01% of the portfolio, ranked #2167.

Invesco first reported a position in BEAM in Q4 2020 and has held it in 22 quarters since. The position peaked at $14.9M in Q4 2020. 251 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.

  • Invesco held 219,961 shares of Beam Therapeutics worth $5.24M as of Q1 2026.
  • Invesco bought 6,776 Beam Therapeutics shares in Q1 2026, an estimated $188K.
  • Beam Therapeutics made up ﹤0.01% of Invesco's portfolio in Q1 2026, its #2167 holding.
  • Invesco first reported a position in Beam Therapeutics in Q4 2020 and has held it in 22 quarters since.
  • Invesco's Beam Therapeutics position peaked at $14.9M in Q4 2020.
  • 251 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.

Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.